Free Trial
OTCMKTS:BCTXF

BriaCell Therapeutics (BCTXF) Stock Price, News & Analysis

BriaCell Therapeutics logo
$4.10 -0.36 (-8.07%)
As of 05/1/2025

About BriaCell Therapeutics Stock (OTCMKTS:BCTXF)

Key Stats

Today's Range
$4.09
$4.50
50-Day Range
$3.18
$6.03
52-Week Range
$3.25
$17.50
Volume
408,158 shs
Average Volume
1,859 shs
Market Capitalization
$3.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Receive BCTXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BCTXF Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
BriaCell confirms 100% resolution of lung metastasis with Bria-OTS
See More Headlines

BCTXF Stock Analysis - Frequently Asked Questions

BriaCell Therapeutics' stock was trading at $0.5558 at the start of the year. Since then, BCTXF stock has increased by 637.7% and is now trading at $4.10.
View the best growth stocks for 2025 here
.

Shares of BCTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:BCTXF
CIK
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,680,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($4.55) per share
Price / Book
-0.90

Miscellaneous

Free Float
N/A
Market Cap
$3.17 million
Optionable
Not Optionable
Beta
1.09
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (OTCMKTS:BCTXF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners